Huiqin Li

Title: Huiqin Li: Innovator in Ginkgolide Pharmaceuticals

Introduction

Huiqin Li is a prominent inventor based in Sichuan, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of ginkgolide derivatives. Her work is characterized by a focus on innovative compounds that have potential therapeutic applications.

Latest Patents

Huiqin Li holds a patent for a Ginkgolide B derivative and its preparation method and use. The patent discloses a compound represented by specific formulas, where R is selected from pyrazinyl or substituted pyrazinyl, and R is selected from pyrazinyl or substituted pyrazinyl, phenyl or substituted phenyl, alkyl or substituted alkyl. This innovative approach highlights her expertise in medicinal chemistry and the development of new pharmaceutical agents.

Career Highlights

Huiqin Li is currently associated with Chengdu Baiyu Ginkgolide Pharmaceuticals Co. Ltd. Her role in the company has allowed her to advance her research and contribute to the development of ginkgolide-based therapies. With a patent portfolio that includes 1 patent, she has established herself as a key figure in her field.

Collaborations

Huiqin Li has worked alongside notable colleagues such as Daxiong Li and Hong Ke. These collaborations have fostered a productive research environment, enabling the exploration of new ideas and innovations in the pharmaceutical sector.

Conclusion

Huiqin Li's contributions to the field of pharmaceuticals, particularly through her innovative patent on ginkgolide derivatives, underscore her role as a leading inventor. Her work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in medicine.